Binding of contactin-1 autoantibodies induces complement deposition and activation.
The highest complement deposition can be found associated with the IgG3 subclass of anti-contactin-1 auto-antibodies.
IVIG inhibits complement deposition in a dose-dependent manner, but does not inhibit binding of auto-antibodies to contactin-1.